Tyrosine is a familiar name on nootropic and “brain fog” supplement labels, marketed for focus, stress resilience, and mental performance. A large new UK Biobank analysis found something considerably less flattering: higher circulating tyrosine levels are associated with a measurably shorter lifespan — specifically in men.
What the Study Actually Did
Published in the journal Aging in March 2026 (Zhao, Sun, Zhang, and Ye), the study combined two research approaches on a genuinely large scale. Researchers first ran a Cox regression analysis on 272,475 UK Biobank participants, examining how baseline blood amino acid levels tracked with mortality over the follow-up period, which recorded 23,964 deaths (14,230 men, 9,734 women). They then followed up with a genome-wide association study and two-sample Mendelian randomization — a method that uses genetic variants as a kind of natural experiment to estimate whether an association is more likely causal, rather than just a correlation driven by some other underlying factor.
The Actual Finding: About a Year of Life Per Standard Deviation
The headline result: genetically predicted higher tyrosine levels were associated with roughly one year of reduced life expectancy per standard-deviation increase in tyrosine — and this effect was substantially stronger in men than in women. The researchers describe the association as “directionally consistent” across both sexes but meaningfully weaker in women, which is itself a notable and not-yet-fully-explained part of the finding.
Why Phenylalanine Dropped Out of the Picture
Tyrosine and phenylalanine are metabolically linked — the body converts phenylalanine into tyrosine, and earlier research had flagged both amino acids as potentially connected to mortality risk. This study’s multivariable analysis clarified that relationship: once tyrosine was controlled for, phenylalanine was no longer independently associated with lifespan in either sex. In other words, tyrosine appears to be the actual driver behind what earlier research had attributed to either amino acid, not a shared or independent effect from both.
What This Study Does and Doesn’t Prove
This is association research strengthened by a genetic-causality method, not a supplementation trial. The researchers themselves flagged real limitations: limited statistical power to fully characterize the sex difference, and partial overlap between the datasets used for the exposure and outcome analyses, which can introduce a specific kind of bias — though they note sensitivity analyses showed the direction of the effect held up regardless. Critically, the researchers are explicit that their findings “reflect the lifelong effect of endogenous circulating levels rather than short-term dietary supplementation.” That distinction matters enormously for anyone reading this as a reason to worry about a tyrosine supplement: this study measured naturally occurring, lifelong blood tyrosine levels shaped by genetics and metabolism, not the effect of taking a tyrosine supplement for weeks or months.
What This Actually Means for Someone Taking a Tyrosine Supplement
This study does not show that taking an over-the-counter tyrosine supplement shortens lifespan — that’s a different question this research wasn’t designed to answer, and no supplementation trial data exists showing that link. What it does suggest is that tyrosine metabolism itself may be a more biologically significant marker of aging and mortality risk than it’s generally treated as, which is scientifically interesting and potentially useful for future research into biomarkers of aging — but it isn’t, on its own, a reason to stop or start a supplement. Anyone currently taking tyrosine for a specific reason (some clinicians use it for certain stress or cognitive-performance contexts) should treat this as new research worth being aware of, not an urgent reason to change course without talking to a doctor first.
How This Fits Into the Broader Amino-Acid-and-Aging Research
This study lands in a growing, still-unsettled body of research looking at how individual amino acids relate to aging and mortality — separate from, but conceptually related to, the newer work on overall protein intake and aging that has produced genuinely conflicting conclusions depending on the population studied. What sets this tyrosine analysis apart is the combination of a very large observational sample with a genetic Mendelian-randomization approach specifically designed to strengthen the case for a causal link, rather than relying on blood-level correlation alone, which is more vulnerable to being explained by some other underlying health condition or behavior. That combination is part of why this finding, despite being preliminary in the sense that it hasn’t been replicated in an independent cohort yet, is being treated as a meaningfully stronger signal than a typical single-cohort correlation study.
Frequently Asked Questions
Should I stop taking a tyrosine supplement because of this study?
This study measured naturally occurring blood tyrosine levels over a lifetime, not the effect of taking a supplement. There’s no direct evidence from this research that supplementation itself shortens lifespan, though it’s reasonable to mention this study to a doctor if you take tyrosine regularly and have questions.
Why would this affect men more than women?
The study found the association was weaker but still directionally present in women; the researchers don’t fully explain why, and this is exactly the kind of open question that tends to drive follow-up research.
Is tyrosine bad for you in general?
Tyrosine is a normal amino acid the body needs and produces as part of standard protein metabolism. This study is about naturally elevated levels correlating with mortality risk, not about tyrosine being inherently harmful at typical dietary levels.
Does diet affect blood tyrosine levels the way this study measured them?
Blood tyrosine levels are influenced by a mix of genetics, overall protein intake, and metabolic factors like liver function, since the body also produces tyrosine internally from phenylalanine. This study’s genetic approach was specifically designed to isolate the lifelong, largely genetically-driven component of that picture, rather than short-term dietary fluctuation.
Final Thoughts
A supplement marketed for sharper focus turning up in a longevity study for the opposite reason is a good reminder that “supports brain function” and “good for long-term health” aren’t automatically the same claim. This is genuinely interesting biomarker research, not a verdict on whether anyone should be taking tyrosine — and the researchers themselves are careful to say so.
For more evidence-based coverage of supplements and longevity research, visit https://gemifys.com/category/wellness/.
